Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Ejiri

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 17, 2024
Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertensionMisaki Kanezawa, Hiroto Shimokawahara, Kentaro Ejiri, et al.
International Journal of Cardiology|April 3, 2026
Combined left and right atrial reservoir strain identifies a high-risk phenotype in patients with chronic heart failureRie Nakayama, Yoichi Takaya, Mitsutaka Nakashima, et al.
BMJ Open|April 1, 2019
The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trialKentaro Ejiri, Toru Miyoshi, Kazufumi Nakamura, et al.
JACC. Advances|June 28, 2024
Feasibility of Treat and Repair Strategy in Congenital Heart Defects With Pulmonary Arterial HypertensionSatoshi Akagi, Shingo Kasahara, Teiji Akagi, et al.
JACC. Asia|March 6, 2023
Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA TrialShun Kohsaka, Kentaro Ejiri, Hidenobu Takagi, et al.
Acta Medica Okayama|October 26, 2016
Feasibility of Repairing Defects Followed by Treatment with Pulmonary Hypertension-specific Drugs (Repair and Treat) in Patients with Pulmonary Hypertension Associated with Atrial Septal Defect: Study Protocol for Interventional TrialSatoshi Akagi, Kazufumi Nakamura, Teiji Akagi, et al.
Pulmonary Circulation|July 10, 2026
Recurrence of Pulmonary Hypertension After Unilateral Lung Transplantation: Histological Evidence of Vasoconstrictive MechanismSatoshi Akagi, Megumi Kondo, Koichi Ichimura, et al.
Vascular Health and Risk Management|May 23, 2015
Epoprostenol sodium for treatment of pulmonary arterial hypertensionYukihiro Saito, Kazufumi Nakamura, Satoshi Akagi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2025
Hemodynamic Changes After Wire Frame Occluders vs. Metal Mesh Devices for Atrial Septal DefectMitsutaka Nakashima, Yoichi Takaya, Kentaro Ejiri, et al.
International Journal of Cardiology. Heart & Vasculature|January 4, 2019
Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trialKentaro Ejiri, Toru Miyoshi, Kunihisa Kohno, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 17, 2024
Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertensionMisaki Kanezawa, Hiroto Shimokawahara, Kentaro Ejiri, et al.
International Journal of Cardiology|April 3, 2026
Combined left and right atrial reservoir strain identifies a high-risk phenotype in patients with chronic heart failureRie Nakayama, Yoichi Takaya, Mitsutaka Nakashima, et al.
BMJ Open|April 1, 2019
The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trialKentaro Ejiri, Toru Miyoshi, Kazufumi Nakamura, et al.
JACC. Advances|June 28, 2024
Feasibility of Treat and Repair Strategy in Congenital Heart Defects With Pulmonary Arterial HypertensionSatoshi Akagi, Shingo Kasahara, Teiji Akagi, et al.
JACC. Asia|March 6, 2023
Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA TrialShun Kohsaka, Kentaro Ejiri, Hidenobu Takagi, et al.
Acta Medica Okayama|October 26, 2016
Feasibility of Repairing Defects Followed by Treatment with Pulmonary Hypertension-specific Drugs (Repair and Treat) in Patients with Pulmonary Hypertension Associated with Atrial Septal Defect: Study Protocol for Interventional TrialSatoshi Akagi, Kazufumi Nakamura, Teiji Akagi, et al.
Pulmonary Circulation|July 10, 2026
Recurrence of Pulmonary Hypertension After Unilateral Lung Transplantation: Histological Evidence of Vasoconstrictive MechanismSatoshi Akagi, Megumi Kondo, Koichi Ichimura, et al.
Vascular Health and Risk Management|May 23, 2015
Epoprostenol sodium for treatment of pulmonary arterial hypertensionYukihiro Saito, Kazufumi Nakamura, Satoshi Akagi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2025
Hemodynamic Changes After Wire Frame Occluders vs. Metal Mesh Devices for Atrial Septal DefectMitsutaka Nakashima, Yoichi Takaya, Kentaro Ejiri, et al.
International Journal of Cardiology. Heart & Vasculature|January 4, 2019
Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trialKentaro Ejiri, Toru Miyoshi, Kunihisa Kohno, et al.
Pageof 9